“It was the first time we jumped from drug discovery to other areas of chemistry. We've always been interested in entering other areas of research, so this was an exciting opportunity for us to demonstrate that. We believe we can lift and shift this technology to benefit other industries.”

“Transferring this technology is a two-way street. Our teams learned how Insilico Medicine’s technology could be adapted but it also helped us learn about the data we generate and its suitability for this technology. This insight will inform how we generate data in future.” 

“My background is in pharmaceuticals so I was sceptical as I had never worked in plant biology. But the expertise and knowledge transfer on scientific problems was really enjoyable as we worked towards finding answers and generating results.”

“There is a limit to how many parameters a human brain can manage when designing a molecule. Insilico Medicine’s AI platform has helped us with multi-dimensional design – optimizing multiple parameters – to deliver effective, safe and sustainable molecules.” 

“Our ambition is to efficiently integrate large DNA fragments into specific genomic locations. Targeted insertion will accelerate R&D, delivering more innovative solutions to farmers, faster.”